Australia markets open in 2 hours 23 minutes
  • ALL ORDS

    7,239.40
    +30.40 (+0.42%)
     
  • AUD/USD

    0.7777
    +0.0047 (+0.60%)
     
  • ASX 200

    7,014.20
    +31.50 (+0.45%)
     
  • OIL

    65.51
    +0.14 (+0.21%)
     
  • GOLD

    1,844.00
    +5.90 (+0.32%)
     
  • BTC-AUD

    57,977.04
    -4,745.11 (-7.57%)
     
  • CMC Crypto 200

    1,398.33
    +39.77 (+2.93%)
     

AbCellera to Present Virtually at Upcoming Investor Conferences

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
  • Oops!
    Something went wrong.
    Please try again later.

AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the following virtual investor conferences:

  • BMO Biopharma Spotlight Series: Technology-Enabled Drug Discovery Panel on Friday, April 16, 2021 at 7:00 a.m. Pacific Time

  • 2021 Bloom Burton & Co. Healthcare Investor Conference on Tuesday, April 20 at 10:30 a.m. Pacific Time

Live audio webcasts of each presentation may be accessed through links that will be posted on AbCellera’s Investor Relations website. A replay of each webcast will be available through the same links following the presentation.

About AbCellera Biologics Inc.

AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce costs, and tackle the toughest problems in drug development. To learn more, please visit us at www.abcellera.com.

Source: AbCellera Biologics Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210412005842/en/

Contacts

Inquiries
Media: Jessica Yingling, Ph.D.; media@abcellera.com, +1(236)521-6774
Business Development: Kevin Heyries, Ph.D.; bd@abcellera.com, +1(604)559-9005
Investor Relations: Melanie Solomon; ir@abcellera.com, +1(778)729-9116